Business
ProAxsis Achieves CE Mark for Plasmin Immunoassay
ProAxsis Achieves CE Mark for Plasmin Immunoassay.
About this update from Emv Capital Plc
[{"type":"text","content":"\n \nRNS Number : 1658B NetScientific PLC 08 January 2018 \n\n \n \nNetScientific plc\n(\"NetScientific\" or the \"Company\" or the \"Group\")\n \nProAxsis Achieves CE Mark and Launches its ProteaseTag® Active Plasmin Immunoassay\n \nLondon, UK - January 8th 2018 - NetScientific plc (\"NetScientific\", AIM:NSCI), the transatlantic healthcare IP commercialisation group, provides an update on its portfolio company ProAxsis, which today announces that it has successfully registered a CE Mark for its ProteaseTag® Active Plasmin Immunoassay, which has potential application in a broad range of disease indications including lung disorders.\nThe Active Plasmin Immunoassay is the first CE-Marked test to enable the specific measurement of the active form of plasmin, the target protease which is widely believed to be involved in the pathogenesis of lung disorders such as idiopathic pulmonary fibrosis (IPF) and acute respiratory distress syndrome (ARDS).\nCommenting on the news, Francois Martelet, Chief Executive Officer of NetScientific and Chairman of ProAxsis, said: \"We are pleased to announce that ProAxsis has registered a third product with a CE Mark, as it continues to commercialise its growing portfolio of novel protease-targeting point-of-care tests. We are also particularly pleased to announce the first product launch with applications in both respiratory health and other disease states including pre-eclampsia, nephrotic syndrome and diabetes mellitus.\"\nNetScientific holds a 57% stake on a fully diluted basis in ProAxsis.\n \nThe full text of the announcement from ProAxsis can be found below.\n \n# # #\n \nFor more information, please contact:\n \n\n\n\n\n NetScientific\n François R. Martelet, M.D., CEO\n Ian Postlethwaite, CFO\n\n\nTel: +44 (0)20 3514 1800\n\n\n\n\n \n Consilium Strategic Communications\n Mary-Jane Elliott / Jessica Hodgson /\n Chris Welsh / Laura Thornton \n \n\n\n \nTel: +44 (0)20 3709 5700\[email protected]\n\n\n\n\nStifel Nicolaus Europe Limited (NOMAD and Broker)\nJonathan Senior / David Arch / Ben Maddison\n\n\n Tel: +44 (0) 20 7710 7600\n\n\n\n\n \n \n \n \n \nProAxsis Launches ProteaseTag® Active Plasmin Immunoassay following CE Mark...